The role of the monocyte in the generation and dissolution of arterial and venous thrombi

Vascular

Volumn 6, Issue 2, 1998, Pages 119-125

  Burnand, K G ^a   Gaffney, P J ^b   Mcguinness, C L ^a   Humphries, J ^a   Quarmby, J W ^a   Smith, A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

arterial; dissolution; monocyte; thrombosis; venous

Indexed keywords

ARTERY THROMBOSIS; FIBRINOLYSIS; HUMAN; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VEIN THROMBOSIS;

ANIMALS; ARTERIES; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; HUMANS; MONOCYTES; RATS; THROMBOSIS; VEINS;

EID: 17944392261     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099800600203     Document Type: Review

References (53)

1. Bachmann F., Laboratory diagnosis of impairment of fibrinolysis in patients with thromboembolic disease. Seminars in Thrombosis and Haematology, 1990, 16, 193–197.
2. Gurewich V., The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase. Fibrinolysis, 1989, 3, 59–66.
3. Plow E. F., Collen D., The presence and release of a-2 antiplasmin from human platelets. Blood, 1981, 58, 1069–1074.
4. Gaffney P. J., Creighton L. J., Callus M., Thorpe R. M., Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II: Evaluation in a variety of clinical conditions. British Journal of Haematology, 1988, 68, 91–96.
5. Hamsten A., Wiman B., De Faire W., Blombach M., Increased plasma levels of a rapid inhibitor of tPA in young survivors of myocardial infarction. New England Journal of Medicine, 1985, 313, 1557–1563.
6. Grulich-Henn J., Muller-Berghaus G., The role of vascular endothelial cells in the regulation of fibrinolysis. Zeitschrift für Kardiologie, 1989, 78 (suppl. 6), 25–29.
7. Laug W. E., Secretion of plasminogen activator by cultured bovine endothelial cells: Partial purification, characterization, and evidence for multiple forms. Thrombosis and Haemostasis, 1981, 45, 219–224.
8. Loskutoff D. J., Van Mourik J. A., Erickson L. A., Lawrence D., Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proceedings of the National Academy of Science USA, 1983, 80, 2956–2960.
9. Speiser W., Anders E., Preissner K. T., et al, Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from ommental tissue microvessels and umbilical veins. Blood, 1987, 69, 964–967.
10. Cooper J. P., Newby A. C., Monocyte adhesion to human saphenous vein in vitro. Atherosclerosis, 1991, 91, 85–95.
11. Colucci M., Balconi G., Lorenzet R., et al, Cultured human endothelial cells generate tissue factor in response to endotoxin. Journal of Clinical Investigation, 1983, 71, 1893–1896.
12. Levin E. G., Marzec U., Anderson M. J., Harker L. A., Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. Journal of Clinical Investigation, 1984, 74, 1988–1995.
13. Schleef R. R., Loskutoff D. J., Podor T. J., Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. Journal of Cell Biology, 1991, 113, 1413–1423.
14. Sakariassen K. S., Joss R., Muggli R., et al, Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis, 1990, 10, 276–284.
15. Mason R. G., Mohammad S. F., Chuang H. Y., et al, The adhesion of platelets to subendothelium, collagen, and artificial surfaces. Seminars in Thrombosis and Haematology, 1976, 3, 98.
16. Davies M. J., Mechanisms of thrombosis in atherosclerosis. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn, ed. Colman R. W., Hirsh J., Marder V. J., Salzman E. B. J.B. Lippincott Company, Philadelphia, 1994, pp. 1224–1237.
17. Davies M. J., Thomas A., Thrombosis in acute coronary-artery lesions in sudden cardiac ischaemic death. New England Journal of Medicine, 1984, 310, 1137–1140.
18. Robbins K. C., A study on the conversion of fibrinogen to fibrin. American Journal of Physiology, 1944, 142, 581.
19. Wessler S., Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. Journal of Clinical Investigation, 1952, 31, 1011–1014.
20. Stewart G. J., Neutrophils and deep venous thrombosis. Haemostasis, 1993, 23, 127–140.
21. Drake T. A., Morrissey J. H., Edgington T. S., Selective cellular expression of tissue factor in human tissues. Implications for disorders of haemostasis and thrombosis. American Journal of Pathology, 1989, 134, 1087–1097.
22. Rodgers G. M., Greenberg C. S., Shuman M. A., Characterisation of the effects of cultured vascular cells on the activation of blood coagulation. Blood, 1983, 61, 1155–1162.
23. Wilcox J. N., Smith K. M., Schwarz S. M., Gordon D., Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Science USA, 1989, 86, 2839–2843.
24. Bevilaqua M. P., Pober J. S., Majeau G. R., et al, Recombinant TNF induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of IL-1. Proceedings of the National Academy of Science USA, 1986, 83, 3460–3464.
25. Drake T. A., Cheng J., Chang A., Taylor F. B., Expression of tissue factor, thrombomodulin and E-selectin in baboons with lethal Escherichia coli sepsis. American Journal of Pathology, 1993, 142, 1458–1470.
26. Baker S. R., Hughes S. E., Zitka M., et al, Tissue factor is more relevant to arterial haemorrhage than to thrombosis. British Journal of Surgery, 1993, 80, 529.
27. Mackman N., Sawdey M. S., Keeton M. R., Loskutoff D. J., Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. American Journal of Pathology, 1993, 143, 76–84.
28. Rickles R. R., Edwards R. L., Leukocytes and tumor cells in thrombosis. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed. Colman R. W., Hirsh J., Marder V. J., Salzman E. B. J.B. Lippincott Company, Philadelphia, 1994.
29. Castellote J. C., Gray E., Linde M. A., et al, Detection of both type-1 and type-2 plasminogen activator inhibitors in human monocytes. Thrombosis and Haemostasis, 1990, 63, 67–71.
30. Edgington T. S., Mackman N., Brand K., Ruf W., The structural biology of expression and function of tissue factor. Thrombosis and Haemostasis, 1991, 66, 67–79.
31. Celi A. B., Pellegrini G., Lorenzet R., et al, P-selectin induces the expression of tissue factor on monocytes. Proceedings of the National Academy of Science USA, 1994, 91, 8767–8771.
32. Gerrity R. G., The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology, 1981, 103, 181–184.
33. Faggiotto A., Ross R., Studies of hypercholesterolaemia in the non-human primate. I. Changes that lead to fatty streak formation. Arteriosclerosis, 1984, 4, 323–326.
34. Davies M. J., Gordon J. L., Gearing A. J. H., et al, The expression of the adhesion molecules ICAM-1, VACM-1, PECAM, and E-selectin in human atherosclerosis. Journal of Clinical Pathology, 1993, 171, 223–229.
35. Poston R. N., Haskard D. O., Coucher J. R., et al, Expression of ICAM-1 in atherosclerotic plaques. American Journal of Pathology, 1992, 140, 665–673.
36. Valente A. J., Rozek M. M., Sprague E. A., Schwartz C. J., Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1. Circulation, 1992, 86, 11120–11125.
37. Sueshi K., Yasunaga C., Murata T., et al, Endothelial function in thrombosis and thrombolysis. Japanese Circulation Journal, 1992, 56, 192–198.
38. Lesnik P., Rouis M., Skarlatos S., et al, Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte derived macrophages. Proceedings of the National Academy of Science USA, 1992, 89, 10370–13074.
39. Wada H., Kaneko T., Wakita Y., et al, Effect of lipoproteins on tissue factor activity and PAI-2 antigen in human monocytes and macrophages. International Journal of Cardiology, 1994, 47, S21-S25.
40. Eggesbo J. B., Hjermann I., Ovstebo R., et al, LPS induced procoagulant activity and plasminogen activator activity in mononuclear cells from persons with high or low levels of HDL lipoprotein. Thrombosis Research, 1995, 77, 41–452.
41. Di Minno G., Cerbone A. M., Postiglione A., et al, Hemostatic variables in homozygous familial hypercholesterolaemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. Arteriosclerosis, 1990, 10, 1119–1126.
42. Tipping P. G., Davenport P., Gallicchio M., et al, Atheromatous plaque macrophages produce PAI-I and stimulates its production by endothelial cells and vascular smooth muscle cells. American Journal of Pathology, 1993, 143, 885.
43. Jaffe E. A., Biochemistry, immunology, and cell biology of endothelium. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn, ed. Colman R. W., Hirsh J., Marder V. J., Salzman E. B. J.B. Lippincott, 1994, pp. 718–744.
44. Northeast A. D. R., Creighton L. J., Gaffney P. J., Burnand K. G., Vein wall fibrinolysis: The response to thrombosis. Annals of the New York Academy of Science, 1992, 667, 127–140.
45. Northeast A. D. R., Soo K. S., Bobrow L. G., et al, The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. Journal of Vascular Surgery, 1995, 22, 573–579.
46. Soo K. S., Northeast A. D. R., Happerfield L. C., et al, Tissue plasminogen activator production by monocytes in venous thrombolysis. Journal of Pathology, 1996, 178, 190–194.
47. Hamilton J. A., Hart P. H., Leizer T., et al, Regulation of plasminogen activator activity in arthritic joints. Journal of Rheumatology, 1991, S27, 106–109.
48. Nykjaer A., Petersen C. M., Christensen E. I., et al, Urokinase receptors in human monocytes. Biochimica Biophysica Acta, 1990, 1052, 399–407.
49. Lundgren C. H., Sawa H., Soble B. E., Fujii S., Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation, 1994, 90, 1927–1934.
50. Kung S. K. P., Lau H. K. F., Modulation of the plasminogen activation system in murine macrophages. Biochimica Biophysica Acta, 1993, 1176, 113–122.
51. Kuraoka S., Campeau J. D., Rodgers K. E., et al, Effects of IL-1 on postsurgical macrophage secretion of protease and protease inhibitor activities. Journal of Surgical Research, 1992, 52, 71–78.
52. Hart P. H., Burgess D. R., Vitti G. F., Hamilton J. A., Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator. Blood, 1989, 74, 1222–1225.
53. Simon D.I., Ezratty A. M., Francis S. A., et al, Fibrinogen is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): A non-plasmin fibrinolytic pathway. Blood, 1993, 82, 2414–2422.